These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 30401437)

  • 21. Motoneuron Disease: Clinical.
    Ilieva H; Maragakis NJ
    Adv Neurobiol; 2017; 15():191-210. PubMed ID: 28674982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].
    Kollewe K; Dengler R; Petri S
    Nervenarzt; 2008 Jun; 79(6):653-61. PubMed ID: 18210046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amyotrophic lateral sclerosis].
    Veldink JH; Weikamp J; Schelhaas HJ; van den Berg LH
    Ned Tijdschr Tandheelkd; 2010; 117(7-8):380-2. PubMed ID: 20726497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole.
    Ceccanti M; Onesti E; Rubino A; Cambieri C; Tartaglia G; Miscioscia A; Frasca V; Inghilleri M
    Brain Stimul; 2018; 11(4):775-781. PubMed ID: 29459142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drugs for Amyotrophic Lateral Sclerosis].
    Ogino M
    Brain Nerve; 2023 May; 75(5):503-506. PubMed ID: 37194520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Interprofessional Approach to Amyotrophic Lateral Sclerosis Care.
    Jaffa JL; Dufault M; Lavin M
    J Neurosci Nurs; 2017 Oct; 49(5):318-323. PubMed ID: 28817498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyotrophic lateral sclerosis associated with pregnancy.
    Tyagi A; Sweeney BJ; Connolly S
    Neurol India; 2001 Dec; 49(4):413-4. PubMed ID: 11799421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
    Goyal NA; Mozaffar T
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular insights and therapeutic targets in amyotrophic lateral sclerosis.
    Tripathi VB; Al-Chalabi A
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):11-9. PubMed ID: 18289027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyotrophic lateral sclerosis.
    Jackson CE; Bryan WW
    Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future.
    Harikrishnareddy D; Misra S; Upadhyay S; Modi M; Medhi B
    Rev Neurosci; 2015; 26(2):161-81. PubMed ID: 25720096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
    Mitsumoto H; Brooks BR; Silani V
    Lancet Neurol; 2014 Nov; 13(11):1127-1138. PubMed ID: 25316019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials.
    Barp A; Gerardi F; Lizio A; Sansone VA; Lunetta C
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):145-164. PubMed ID: 32456491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amyotrophic lateral sclerosis, a heterogeneous disorder].
    van Es MA; Kruitwagen-van Reenen ET; Schröder CD; Pasterkamp RJ; Veldink JH; van den Berg LH
    Ned Tijdschr Geneeskd; 2016; 160():A9658. PubMed ID: 26860749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.
    Moujalled D; White AR
    CNS Drugs; 2016 Mar; 30(3):227-43. PubMed ID: 26895253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussion.
    Brooks BR; Jorgenson JA; Newhouse BJ; Shefner JM; Agnese W
    Am J Manag Care; 2018 Apr; 24(9 Suppl):S175-S186. PubMed ID: 29693363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiological and diagnostic implications of cortical dysfunction in ALS.
    Geevasinga N; Menon P; Özdinler PH; Kiernan MC; Vucic S
    Nat Rev Neurol; 2016 Nov; 12(11):651-661. PubMed ID: 27658852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis.
    Konopka A; Atkin JD
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.